GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.1592
-0.0809 (-33.69%)
At close: Dec 19, 2025, 4:00 PM EST
0.1597
+0.0005 (0.31%)
After-hours: Dec 19, 2025, 7:59 PM EST
GeoVax Labs Revenue
GeoVax Labs had revenue of $3.35M in the twelve months ending September 30, 2025. In the year 2024, GeoVax Labs had annual revenue of $3.95M.
Revenue (ttm)
$3.35M
Revenue Growth
+8.52%
P/S Ratio
0.74
Revenue / Employee
$197,268
Employees
17
Market Cap
4.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.95M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
| Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
| Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
| Dec 31, 2019 | 1.18M | 212.69K | 22.08% |
| Dec 31, 2018 | 963.20K | -112.07K | -10.42% |
| Dec 31, 2017 | 1.08M | 246.35K | 29.72% |
| Dec 31, 2016 | 828.92K | 400.84K | 93.64% |
| Dec 31, 2015 | 428.08K | -454.88K | -51.52% |
| Dec 31, 2014 | 882.96K | -1.53M | -63.48% |
| Dec 31, 2013 | 2.42M | -239.78K | -9.02% |
| Dec 31, 2012 | 2.66M | -2.24M | -45.77% |
| Dec 31, 2011 | 4.90M | -285.37K | -5.50% |
| Dec 31, 2010 | 5.19M | 1.52M | 41.36% |
| Dec 31, 2009 | 3.67M | 758.03K | 26.05% |
| Dec 31, 2008 | 2.91M | 2.67M | 1,127.90% |
| Dec 31, 2007 | 237.00K | -615.90K | -72.21% |
| Dec 31, 2006 | 852.91K | 182.44K | 27.21% |
| Dec 31, 2005 | 670.47K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GOVX News
- 5 weeks ago - GeoVax Labs, Inc. (GOVX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 1 year ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 1 year ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire